Journal of Clinical Tuberculosis and Other Mycobacterial Diseases (Aug 2019)

Mycobacterium tuberculosis-specific cytokine biomarkers for the diagnosis of childhood TB in a TB-endemic setting

  • Eva L. Sudbury,
  • Larissa Otero,
  • Marc Tebruegge,
  • Nicole L. Messina,
  • Carlos Seas,
  • Martin Montes,
  • Julia Rìos,
  • Susie Germano,
  • Kaya Gardiner,
  • Vanessa Clifford,
  • Eduardo Gotuzzo,
  • Nigel Curtis

Journal volume & issue
Vol. 16

Abstract

Read online

The tuberculin skin test and interferon-gamma release assays have limitations in diagnosing tuberculosis (TB), particularly in children. This study investigated the performance of candidate M. tuberculosis-specific cytokine biomarkers for TB in children in a TB-endemic setting. A total of 237 children with a household contact with smear-positive pulmonary TB were recruited. Importantly, a group of children with illnesses other than TB (sick controls) was included to assess specificity.Median IFN-ɣ, IL-1ra, IL-2, IL-13, IP-10, MIP-1β and TNF-α responses were significantly higher in children with active TB and latent TB infection (LTBI) than in both healthy and sick control children. Three of these cytokines – IL-2, IL-13 and IP-10 – showed better performance characteristics than IFN-ɣ, with IL-2 achieving positive and negative predictive values of 97.7% and 90.7%, respectively. Furthermore, IL-1ra and TNF-α responses differed significantly between active TB and LTBI cases, suggesting that they may be stage-specific biomarkers.Our data indicate that incorporating these biomarkers into future blood-based TB assays could result in substantial performance gains. Keywords: Tuberculosis, Cytokine biomarkers, Interferon-gamma release assay, Tuberculin skin test, TB-endemic